PS1399 REAL WORLD DATA ON THE EFFICACY AND SAFETY OF DARATUMUMAB FOR TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS: A MULTI-SITE RETROSPECTIVE STUDY

Authors :: N. Lavie
S. Levi
M. Gatt
I. Avivi
I. Vaxman
T. Shragai
T. Tadmor
M. Zektser
Y.C. Cohen
O. Rouvio
Source :: HemaSphere. 3:642-643
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Pediatrics
medicine.medical_specialty
business.industry
Relapsed refractory
medicine
Multi site
AL amyloidosis
Daratumumab
Retrospective cohort study
Hematology
business
medicine.disease
Real world data

Tools